Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls

Executive Summary

The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.

You may also be interested in...



Corza Medical Buys BPI To Advance Surgeon-Centered Strategy In Ophthalmology

Corza Medical, a private equity-backed surgical technologies company, has acquired Barron Precision Instruments to expand its ophthalmology surgery business and manufacturing capacity. Earlier in the year, Corza bought Katena Products, a developer of ophthalmic instruments for surgical and in-office applications.

CMS Advisory Panel Provides Some Potential Good News For Glaukos

Rate adjustment recommendations to US Medicare could result in less drastic reimbursement cuts for Glaukos than those currently on the table.

Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line

The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel